J Reconstr Microsurg
DOI: 10.1055/a-2491-3381
Original Article

A Combined “Vasculoplastic” Approach to the Vasculopathic Patient Undergoing Limb Salvage: Understanding the Role of Endovascular Revascularization for Lower Extremity Free Tissue Transfer

1   Department of Plastic and Reconstructive Surgery, MedStar Georgetown University Hospital, Washington, District of Columbia
2   Georgetown University School of Medicine; Washington, District of Columbia
,
1   Department of Plastic and Reconstructive Surgery, MedStar Georgetown University Hospital, Washington, District of Columbia
,
Christian X. Lava
1   Department of Plastic and Reconstructive Surgery, MedStar Georgetown University Hospital, Washington, District of Columbia
2   Georgetown University School of Medicine; Washington, District of Columbia
,
Nisha J. Gupta
2   Georgetown University School of Medicine; Washington, District of Columbia
,
Cecelia M. Hidalgo
2   Georgetown University School of Medicine; Washington, District of Columbia
,
Nicole C. Episalla
1   Department of Plastic and Reconstructive Surgery, MedStar Georgetown University Hospital, Washington, District of Columbia
,
Cameron M. Akbari
3   Department of Vascular Surgery, MedStar Georgetown University Hospital; Washington, District of Columbia
,
Karen K. Evans
1   Department of Plastic and Reconstructive Surgery, MedStar Georgetown University Hospital, Washington, District of Columbia
› Author Affiliations
Funding None.

Abstract

Background Multidisciplinary care with vascular surgery and plastic surgery is essential for lower extremity free flap (LEFF) success in the chronic wound population with diabetes and peripheral vascular disease. There is a lack of understanding on performing targeted direct endovascular reperfusion on a vessel that will be used as the flap recipient. Our study compares outcomes of patients who received targeted revascularization (TR) to the recipient vessel for LEFF anastomosis versus nontargeted revascularization (NR) of arterial recipients prior to LEFF.

Methods LEFF patients who underwent preoperative endovascular revascularization (ER) from July 2011 to January 2023 were reviewed. Location of ER, demographics, perioperative details, and outcomes were collected. TR was performed on the same vessel as the flap recipient and NR was located on a different vessel than the flap recipient.

Results A total of 55 LEFF patients were identified. Overall, 50.91% (n = 28) received TR and 49.1% (n = 27) received NR. Average age was 60.3 ± 10.9 years and average Charlson Comorbidity Index was 5.3 ± 1.9. On preoperative angiogram, the TR group had significantly lower rates of ER above the knee (3.6 vs. 33.3%, p < 0.001). Immediate flap success rate was 98.2%, with no differences between groups (p = 1.000). No significant differences were found in rates of any postoperative flap complications (p = 0.898), takeback (p = 0.352), partial flap necrosis (p = 0.648), or dehiscence (p = 0.729). Both TR and NR groups had similar rates of a postoperative angiogram (42.9 vs. 48.2%, p = 0.694) and reintervention (35.7 vs. 40.7% p = 0.701). Amputation rates were similar between TR and NR (17.9 vs. 14.8%, p = 1.000).

Conclusion Close follow-up with vascular and plastic surgery is required for patients who undergo ER prior to LEFF, as nearly half of our cohort required additional endovascular procedures. Overall, we observed no significant differences in complication rates for the TR and NR groups, informing revascularization strategies for free tissue transfer in a highly comorbid chronic wound population.



Publication History

Received: 13 March 2024

Accepted: 23 November 2024

Article published online:
27 December 2024

© 2024. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Endara M, Ducic I, Attinger C. Free tissue transfer for limb salvage in high-risk patients: worth the risk. Adv Wound Care (New Rochelle) 2013; 2 (02) 63-68
  • 2 Bovill JD, Huffman SS, Deldar R. et al. Long-term outcomes in patients with peripheral arterial disease who undergo free flap reconstruction for chronic lower extremity wounds. Ann Plast Surg 2023; 90 (01) 61-66
  • 3 Romiti M, Albers M, Brochado-Neto FC, Durazzo AE, Pereira CA, De Luccia N. Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia. J Vasc Surg 2008; 47 (05) 975-981
  • 4 Varela C, Acin F, De Haro J, March J, Florez A, Lopez-Quintana A. Influence of surgical or endovascular distal revascularization of the lower limbs on ischemic ulcer healing. J Cardiovasc Surg (Torino) 2011; 52 (03) 381-389
  • 5 Bunte MC, Shishehbor MH. Angiosome-guided intervention in critical limb ischemia. Interv Cardiol Clin 2017; 6 (02) 271-277
  • 6 Igari K, Kudo T, Toyofuku T. et al. Combined arterial reconstruction and free tissue transfer for patients with critical limb ischemia. Ann Vasc Dis 2013; 6 (04) 706-710
  • 7 Bekeny JC, Alfawaz A, Day J. et al. Indirect endovascular revascularization via collaterals: a new classification to predict wound healing and limb salvage. Ann Vasc Surg 2021; 73: 264-272
  • 8 Janhofer DE, Lakhiani C, Kim PJ. et al. The utility of preoperative arteriography for free flap planning in patients with chronic lower extremity wounds. Plast Reconstr Surg 2019; 143 (02) 604-613
  • 9 DeFazio MV, Han KD, Akbari CM, Evans KK. Free tissue transfer after targeted endovascular reperfusion for complex lower extremity reconstruction: setting the stage for success in the presence of mutlivessel disease. Ann Vasc Surg 2015; 29 (06) 1316.e7-1316.e15
  • 10 Kim KG, Meshkin DH, Tirrell AR. et al. A systematic review and meta-analysis of endovascular angiosomal revascularization in the setting of collateral vessels. J Vasc Surg 2021; 74 (04) 1406-1416.e3
  • 11 Meyer A, Goller K, Horch RE. et al. Results of combined vascular reconstruction and free flap transfer for limb salvage in patients with critical limb ischemia. J Vasc Surg 2015; 61 (05) 1239-1248
  • 12 Black C, Fan KL, Defazio MV. et al. Limb salvage rates and functional outcomes using a longitudinal slit arteriotomy end-to-side anastomosis for limb-threatening defects in a high-risk patient population. Plast Reconstr Surg 2020; 145 (05) 1302-1312
  • 13 Spoer DLG, Berger LE, Huffman SS. et al. Longitudinal slit arteriotomy end-to-side anastomosis for free tissue transfer in high-risk limb salvage procedures. . Microsurgery 2023
  • 14 DeFazio MV, Fan KL, Evans KK. Greater saphenous vein-patch interposition to facilitate flow-sparing microanastomosis of calcified arteries in the distal lower extremity. Plast Reconstr Surg 2019; 144 (02) 340e-341e
  • 15 Kim PJ, Evans KK, Steinberg JS, Pollard ME, Attinger CE. Critical elements to building an effective wound care center. J Vasc Surg 2013; 57 (06) 1703-1709
  • 16 Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40 (05) 373-383
  • 17 Huffman SS, Bovill JD, Deldar R. et al. Comparison of Charlson Comorbidity Index and modified 5-factor frailty index as clinical risk stratification tools in predicting adverse outcomes in patients undergoing lower extremity free-flap reconstruction. J Reconstr Microsurg 2023; 39 (06) 419-426
  • 18 Attinger CE, Evans KK, Bulan E, Blume P, Cooper P. Angiosomes of the foot and ankle and clinical implications for limb salvage: reconstruction, incisions, and revascularization. Plast Reconstr Surg 2006; 117 (07) , Suppl): 261S-293S
  • 19 Malik TF, Tivakaran VS. Percutaneous Transluminal Coronary Angioplasty. StatPearls; 2024
  • 20 Papavassiliou VG, Walker SR, Bolia A, Fishwick G, London N. Techniques for the endovascular management of complications following lower limb percutaneous transluminal angioplasty. Eur J Vasc Endovasc Surg 2003; 25 (02) 125-130
  • 21 Pentecost MJ, Criqui MH, Dorros G. et al. Guidelines for peripheral percutaneous transluminal angioplasty of the abdominal aorta and lower extremity vessels. A statement for health professionals from a special writing group of the Councils on Cardiovascular Radiology, Arteriosclerosis, Cardio-Thoracic and Vascular Surgery, Clinical Cardiology, and Epidemiology and Prevention, the American Heart Association. Circulation 1994; 89 (01) 511-531
  • 22 Bosch JL, Hunink MG. Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease. Radiology 1997; 204 (01) 87-96
  • 23 Kavurma MM, Bursill C, Stanley CP. et al. Endothelial cell dysfunction: implications for the pathogenesis of peripheral artery disease. Front Cardiovasc Med 2022; 9: 1054576
  • 24 Midttun M, Sejrsen P, Paaske WP. Peripheral blood flow rates and microvascular responses to orthostatic pressure changes in claudicants before and after revascularisation. Eur J Vasc Endovasc Surg 1999; 17 (03) 225-229
  • 25 Dhar SC, Taylor GI. The delay phenomenon: the story unfolds. Plast Reconstr Surg 1999; 104 (07) 2079-2091
  • 26 Lorenzetti F, Salmi A, Ahovuo J, Tukiainen E, Asko-Seljavaara S. Postoperative changes in blood flow in free muscle flaps: a prospective study. Microsurgery 1999; 19 (04) 196-199
  • 27 Osmundson PJ, Rooke TW, Hallett JW. Effect of arterial revascularization on transcutaneous oxygen tension of the ischemic extremity. Mayo Clin Proc 1988; 63 (09) 897-902
  • 28 Dorweiler B, Neufang A, Schmiedt W. et al. Limb trauma with arterial injury: long-term performance of venous interposition grafts. Thorac Cardiovasc Surg 2003; 51 (02) 67-72
  • 29 Danielsson P, Truedsson L, Norgren L. Systemic white blood and endothelial cell response after revascularization of critical limb ischemia is only influenced in case of ischemic ulcers. Int Angiol 2006; 25 (03) 310-315
  • 30 Husmann M, Dörffler-Melly J, Kalka C, Diehm N, Baumgartner I, Silvestro A. Successful lower extremity angioplasty improves brachial artery flow-mediated dilation in patients with peripheral arterial disease. J Vasc Surg 2008; 48 (05) 1211-1216
  • 31 Akamatsu D, Sato A, Goto H. et al. Nitroglycerin-mediated vasodilatation of the brachial artery may predict long-term cardiovascular events irrespective of the presence of atherosclerotic disease. J Atheroscler Thromb 2010; 17 (12) 1266-1274
  • 32 Pellegrino T, Storto G, Filardi PP. et al. Relationship between brachial artery flow-mediated dilation and coronary flow reserve in patients with peripheral artery disease. J Nucl Med 2005; 46 (12) 1997-2002
  • 33 Al-Hamali S, Baskerville P, Fraser S, Walters H, Markus HS. Detection of distal emboli in patients with peripheral arterial stenosis before and after iliac angioplasty: a prospective study. J Vasc Surg 1999; 29 (02) 345-351
  • 34 Deldar R, Gupta N, Bovill JD. et al. Risk-stratified anticoagulation protocol increases success of lower extremity free tissue transfer in the setting of thrombophilia. Plast Reconstr Surg 2023; 152 (03) 653-666
  • 35 Bradbury AW, Adam DJ, Bell J. et al. BASIL trial Participants. Bypass versus angioplasty in severe ischaemia of the leg (BASIL) trial: an intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy. J Vasc Surg 2010; 51 (5, Suppl): 5S-17S
  • 36 Darling JD, McCallum JC, Soden PA. et al. Results for primary bypass versus primary angioplasty/stent for lower extremity chronic limb-threatening ischemia. J Vasc Surg 2017; 66 (02) 466-475
  • 37 White CJ, Gray WA. Endovascular therapies for peripheral arterial disease: an evidence-based review. Circulation 2007; 116 (19) 2203-2215
  • 38 Baril DT, Marone LK, Kim J, Go MR, Chaer RA, Rhee RY. Outcomes of endovascular interventions for TASC II B and C femoropopliteal lesions. J Vasc Surg 2008; 48 (03) 627-633
  • 39 Faglia E, Mantero M, Caminiti M. et al. Extensive use of peripheral angioplasty, particularly infrapopliteal, in the treatment of ischaemic diabetic foot ulcers: clinical results of a multicentric study of 221 consecutive diabetic subjects. J Intern Med 2002; 252 (03) 225-232
  • 40 Alexandrescu V, Hubermont G. Primary infragenicular angioplasty for diabetic neuroischemic foot ulcers following the angiosome distribution: a new paradigm for the vascular interventionist?. Diabetes Metab Syndr Obes 2011; 4: 327-336
  • 41 Borozan PG, Schuler JJ, Spigos DG, Flanigan DP. Long-term hemodynamic evaluation of lower extremity percutaneous transluminal angioplasty. J Vasc Surg 1985; 2 (06) 785-793
  • 42 Balmer H, Mahler F, Do DD, Triller J, Baumgartner I. Balloon angioplasty in chronic critical limb ischemia: factors affecting clinical and angiographic outcome. J Endovasc Ther 2002; 9 (04) 403-410
  • 43 Giles KA, Pomposelli FB, Spence TL. et al. Infrapopliteal angioplasty for critical limb ischemia: relation of TransAtlantic InterSociety Consensus class to outcome in 176 limbs. J Vasc Surg 2008; 48 (01) 128-136
  • 44 Schmidt A, Ulrich M, Winkler B. et al. Angiographic patency and clinical outcome after balloon-angioplasty for extensive infrapopliteal arterial disease. Catheter Cardiovasc Interv 2010; 76 (07) 1047-1054
  • 45 Schillinger M, Minar E. Restenosis after percutaneous angioplasty: the role of vascular inflammation. Vasc Health Risk Manag 2005; 1 (01) 73-78
  • 46 Gallino A, Mahler F, Probst P, Nachbur B. Percutaneous transluminal angioplasty of the arteries of the lower limbs: a 5 year follow-up. Circulation 1984; 70 (04) 619-623
  • 47 Schillinger M, Exner M, Mlekusch W. et al. Vascular inflammation and percutaneous transluminal angioplasty of the femoropopliteal artery: association with restenosis. Radiology 2002; 225 (01) 21-26
  • 48 Thiruvoipati T, Kielhorn CE, Armstrong EJ. Peripheral artery disease in patients with diabetes: epidemiology, mechanisms, and outcomes. World J Diabetes 2015; 6 (07) 961-969
  • 49 Paneni F, Beckman JA, Creager MA, Cosentino F. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Eur Heart J 2013; 34 (31) 2436-2443